Soligenix Inc

Soligenix Inc is a US late-stage biopharmaceutical company focused on developing and commercialising products for rare diseases and conditions with unmet medical needs. Its primary aim is to improve patient outcomes through innovative therapeutic solutions. Operating within the biopharmaceutical sector, Soligenix Inc focuses on advancing a pipeline of novel treatments and a heat-stable vaccine technology. Its work aims to address critical health challenges, providing new therapeutic options for patients globally. Keep up to date on the latest share price changes by adding SNGX stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.